In a significant shift, India’s capital expenditure from FY25-30 is set to pivot from public-led transport infrastructure to a more balanced investment in energy infrastructure, according to a recent BNP Paribas report. This move, which includes electricity generation and the integration of power grids, is poised to transform the energy sector, enhancing efficiency in transmission and distribution.
This strategic reorientation comes at a time when India’s economy is exhibiting remarkable resilience despite global trade uncertainties and shifting monetary policies. Larger economies like India, China, and the US are less reliant on external trade, making them relatively insulated from the economic risks associated with tariff wars. India’s inward-focused economy is likely to experience less volatility in trade compared to smaller, trade-dependent nations, providing a stable backdrop for this infrastructure pivot.
The financial landscape is also evolving, with the US 10-year bond yield increasing from 3.7% in September 2024 to 4.5% currently, while India’s 10-year yield has remained relatively stable, fluctuating between 6.7% and 6.9%. This narrowing yield gap has contributed to a 3% depreciation of the Indian Rupee (INR) since September 2024. BNP Paribas economists anticipate that US inflation will continue to face upward pressures, preventing any rate cuts in 2025. Meanwhile, the Reserve Bank of India (RBI) may lean towards rate cuts to support economic growth, further compressing the yield gap and exerting downward pressure on the INR.
The investment momentum in India is robust, with both consumer staples and industrials trading at a premium compared to their historical valuation averages and against other emerging markets. While industrials have gained from India’s strong manufacturing momentum, consumer staples are expected to undergo a period of time correction. The strong capital expenditure (capex) momentum, especially in energy infrastructure, is expected to continue, with infrastructure investments remaining robust.
The healthcare sector is also projected to see steady revenue growth, with an expected aggregate growth rate of 10% and an EBITDA margin of 27% in FY26. However, pharma companies may face revenue losses as certain one-off opportunities diminish by the end of 2025. New approvals and product integrations will be crucial factors to watch. While US tariffs on Indian healthcare products remain a possibility, they are unlikely due to the US’s heavy reliance on Indian pharmaceutical supplies.
This news has profound implications for the energy sector. The pivot towards energy infrastructure signals a commitment to addressing long-standing issues in power generation and distribution. Enhanced grid integration could lead to more efficient energy transmission, reducing losses and improving reliability. This could attract significant private investment, further boosting the sector’s growth.
Moreover, the focus on energy infrastructure could catalyze innovation in renewable energy sources, aligning with India’s ambitious renewable energy targets. As the country aims to achieve 500 GW of renewable energy capacity by 2030, investments in grid integration and storage solutions will be crucial. This could position India as a global leader in renewable energy, attracting international collaborations and investments.
The potential rate cuts by the RBI, coupled with the stable economic outlook, could make financing for these infrastructure projects more accessible and affordable. This could further stimulate growth in the energy sector, creating a virtuous cycle of investment and development.
However, the depreciation of the INR could pose challenges, particularly for imports of critical technologies and equipment for energy infrastructure projects. This could necessitate a greater focus on domestic manufacturing and innovation, potentially accelerating India’s journey towards self-reliance in the energy sector.
The premium valuations in consumer staples and industrials, along with the expected time correction in consumer staples, could lead to a reallocation of investments towards the energy sector. This could provide additional impetus for the growth of energy infrastructure, further bolstering the sector’s prospects.
In the healthcare sector, the steady revenue growth and high EBITDA margins could make it an attractive investment destination. However, the potential revenue losses for pharma companies underscore the need for continuous innovation and strategic planning. The reliance of the US on Indian pharmaceutical supplies could provide a buffer against potential tariffs, but companies will need to remain vigilant and adaptive.
Over
